Skip to Content

COVID-19 Info: Vaccines (5 & up) | Boosters | Testing | Visitor Guidelines | Stats | More

IMPORTANT NOTICE: COVID-19 testing appointments are not available at Cone Health emergency departments or urgent care locations. Click here for testing options.

Cone Health Pharmacy Residency Program

Interested in applying for a pharmacy residency?

Contact one of our current pharmacy residents directly for more information!
Webinar links are located at the bottom of the page in the Residency Recruitment Information tab.

Follow us on Facebook and Instagram @mcpharmacyresidency


  • Franco S, Goriacko P, Rosen O, Morgan‐Joseph T. Incidence of Complications Associated with Parenteral Nutrition in Preterm Infants < 32 Weeks with a Mixed Oil Lipid Emulsion vs a Soybean Oil Lipid Emulsion in a Level IV Neonatal Intensive Care Unit. J. Parenter Enter Nutr. 2020 Sep:1-9.
  • Kim J, Powers S, Rice C, Cawley P. Interprofessional medication self-management program for older underserved adults. Patient Prefer Adherence. 2020:14;839-845.
  • Barnes JN, Ton M, Dunham S, Wadsworth D, Sprague T, Kim J. Diabetes management part 1: Everything insulin. Tl;dr pharmacy. 2019 June 17.
  • Barnes JN, Ton M, Dunham S, Wadsworth D, Sprague T, Kim J. Diabetes management part 2: Building a regimen. Tl;dr pharmacy. 2019 July 3.
  • Evaluation of the Accuracy of Different Methods Used to Estimate Ideal Body Weight in the Pediatric Population J Pediatr Pharmacol Ther 2019;24(5):421-430 - Kenny Kang, Randy Absher, Elizabeth Farrington, Renee Ackley and Tsz- Yin So
  • A Review on the Use of Cystic Fibrosis Transmembrane Conductance Regulator Gene Modulators in Pediatric Patients. J Pediatr Health Care 2019; 33:356-364 - Michael Bitonti, Laura Fritts and Tsz-Yin So
  • The Use of Codeine and Tramadol in the Pediatric Population – What is the Verdict Now? J Pediatr Health Care 2019;33:117-123 - Megan Fortenberry, Justin Crowder and Tsz-Yin So
  • A Literature Review on the Use of Dornase Alfa in Pediatric Patients with Lower Respiratory Tract Illnesses other than Cystic Fibrosis. Arch Pediatr Neonatol 2018;1(1):26-35 - Radha Patel and Tsz-Yin So
  • Evaluation of the Efficacy of a Onetime Injectable Dexamethasone Administered Orally in the Pediatric Emergency Department for Asthma Exacerbation. J Pediatr Pharmacol Ther 2017;22(5):326-331 - McCallister A, So TY. 
  • Treatment of Pediatric Clostridium difficile Infection: A Review on Treatment Efficacy and Economic Value. Infect Drug Resist 2017;10:365-375 - D’Ostroph AR, So TY. 
  • Assessing Medication Adherence at a Student-Run Free Health Clinic.  Journal of Student Run Free Clinics. Vol 3 No 1. Sept 17, 2017. - Lam FW, Kaplan MC, Gazda NP, Shah MD, Toler JA, Scolaro, KL. 
  • Impact of Developing Adult Ketamine Order Panels for the Emergency Department. Hosp Pharm 2017;1-5 - Baird H, Rumbarger R. 
  • Real-world Experience with Oritavancin Therapy in Invasive Gram-Positive Infections. Infect Dis Ther 2017;6:277-289 - Stewart C, Turner M, Frens J, Snider C, Smith J.  
  • Elements of Success for Transitioning to the Role of Director of Pharmacy. Am J Health Syst Pharm 2017;74:557-561 - Granko RP, Thompson JM, Morton CS, Little JD. 
  • Comparison of Two Medication Therapy Management Practice Models on Return on Investment. J Pharm Pract 2017;30(3):282-285 - Gazda NP, Ferreri S. Berenbrok L. 
  • Strategy for Pharmacy Data Management. Am J Health Syst Pharm 2017;74:79-85 - Wolfe A, Hess L, La MK, Pappas AL, Moore R, Granko RP, Daniels, R. 
  • Current Clinical Trials on the Use of Ceftaroline in the Pediatric Population. Clin Drug Investig 2017; 37(7):625-634 - Corey A, So TY. 
  • Primary Immunization of Human Papillomavirus Vaccine in the Pediatric Population – What Is the Verdict Now? Clin Pediatr (Phila) 2017;56(7):605-615 - Jones AN, Barlett JW, Bates RA, So TY. 
  • The Use of Citrulline for Pediatric Pulmonary Hypertension. Res J Clin Pediatr 2017;1:1-6 - Yang S, So TY. 
  • Pharmacy Practice: Exploring the Relationship between SSRIs and Sodium Levels in an Older Adult Population. Inov Pharm. 2016;7(4): Article 14. - Anderson SL, Johnston N. 
  • Pharmacists’ Impact on Opportunistic Infection Prophylaxis in Patients with HIV/AIDS. J Hosp Infect 2016;94(4):389-392 - Schatz K, Guffey W, Maccia M, Templin M, Rector K. 
  • Medication Use Evaluation of Dronedarone in Comparison to Amiodarone. Inov Pharm2016;7(4): Article 18. - Corey A, Johnston N. 
  • Medication Reconciliation Limitations: Observation of the Medication Reconciliation Process in the Emergency Department by Two Immersion Pharmacy Students. Inov Pharm2016;7(4): Article 4. - Chong C, Haile A. 
  • Medication Adherence Survey: A First Year Pharmacy Immersion Students’ Perspective. Inov Pharm. 2016;7(3): Article 8. - Ortiz Lopez CF, Li M, Johnston N. 
  • Patient Medication Use: Interpreting the Results of a Patient Medication Safety Survey by Phase I Immersion Pharmacy Students. Inov Pharm2016;7(3): Article 4. - Li M, Ortiz Lopez CF, Johnston N, et al. 
  • Attention Deficit Hyperactive Disorder and Occurrence of Tic Disorders in Children and Adolescents-What is the Verdict Now? Curr Pediatr Rev. 2016;12(3):230-238 - Cooke T, So TY. 
  • Standardize Practice to Identify IV Errors. Pharmacy Purchasing and Products, May 2016, page 20 - Granko RP, McCallister A. 
  • Transitioning antimicrobials from intravenous to oral in pediatric acute uncomplicated osteomyelitis. World J Clin Pediatr 2016; 5(3): 244-250 - Batchelder N, So TY. 
  • Hypersensitivity Reaction to Insulin Glargine and Insulin Detemir in a Pediatric Patient: A Case Report. J Pediatric Pharmacol Ther. 2016;21(1):85-91 - Badik J, Chen J, Letvak K, So TY.  
  • Current Clinical Trials on the Use of Direct Oral Anticoagulants in the Pediatric Population. Cardio Ther 2016;5(1):19-41 - von Vajna E, Alam, R, So TY. 
  • The Use of Penicillin for the Prevention of Pneumococcal Infection in Pediatric Patients with Sickle Cell Disease. J Pediatr Sci 2015;7:e246 - Lawuyi B, Basham J, So TY. 
  • The Risk of Musculoskeletal Adverse Events with Fluuroquinolones in Children: What is the Verdict Now? Clin Pediatr 2016; 55(2):107-110 - Binz J, Adler C, So TY. 
  • Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease. J Pediatric Pharmacol Ther. 2015;20(3):163-177 - Saneeymehri S, Baker K, So TY. 
  • Promoting Pharmacy Business Success through the Implementation of a Departmental Operating Review Series. Am J Health Syst Pharm 2015; 72:610-613 - Granko RP, Lamm M. 
  • Assessing the Personal Performance And Professional Self-development Potential of a Pharmacy Management Practitioner. Am J Health Syst Pharm 2015; 72:149-157 - Granko RP, Wolfe A, Morton C,
  • Ali A, Kim JJ, Pisano M. Beta adrenergic antagonists and antianginal drugs. Side Effects of Drugs Annual. 2019;41:197-205.
  • Bui A, Kwon J, Kim J, Lucas A. Overcoming barriers to statin adherence. U.S. Pharm. 2019 June;19-22. Medscape:
  • Tillman F, Kim JJ, Osae L, Makhlouf T. Heart failure treatment in African Americans. Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719840192.
  • Vincent R, Kim JJ, Patel V, Ahmed T. Pharmacist initiative to increase statin prescribing in diabetes patients. J Pharm Pract. 2019 Jan 29:1-7.
  • Ali A, Kim JJ, Pisano M, Hudgins DK, Wireku M, Ray SD. Beta adrenergic antagonists and antianginal drugs. Side Effects of Drugs Annual. 2018;40:243-252.
  • Koval P, Kim JJ, Makhlouf TK. Perceptions of a mobile application audience response system for remote pharmacy continuing education participants. J Pharm Pract. 2018 Aug:1-5.
  • Tillman F III, Kim J. Select medications that unexpectedly lower HbA1c levels. J Clin Pharm Ther. 2018 Aug;43(4):587-590.
  • Kim JJ, Combs K, Downs J, Tillman F. Medication adherence, the elephant in the room. U.S. Pharm. 2018;43(1):30-34.
  • Aguilar C, Sartori M, D'Angelo A, Kabrhel C, Groce J, et al. Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management study. DiET Study Group. Blood Coagul Fibrinolysis. 2018 Sep;29(6):562-566.
  • Kim JJ, Hill HL, Groce JB 3rd, Granfortuna JM, Makhlouf TK. Pharmacy Student Monitoring of Direct Oral Anticoagulants. J Pharm Pract. 2018 Oct;31(5):462-468.
  • Wild, D. Featuring Combs K, Kim JJ, Gazda N. Optimizing opioid prescribing. ASHP Intersections:
  • Combs K, Kim JJ, Gazda N. Pharmacist intervention to monitor and reduce opioid use in patients with chronic non-cancer pain as part of an interdisciplinary pilot monitoring program. 2018. ASHP Resources:
  • Kirk JK, Edwards R, Brewer A, Miller C, Bray B, Groce JB. Overview of a pharmacist anticoagulation certificate program. Curr Pharm Teach Learn. 2017 Jul;9(4):707-712.
  • Combs K, Kim JJ. Let’s talk: medication adherence. Pharmacy Times. 2017 Jul.
  • Corey A, Kim JJ. Prescribing patterns of statin therapy compared to American Diabetes Association Standards of Care at an academic internal medicine center. NC Pharmacists Journal. 2017 Spring;97(2):32-36.
  • Kim JJ, D’Ostroph A. Tips for managing adverse drug reactions. Pharmacy Times. 2017 Jan.
  • Ali A, Kim JJ, Pisano M, Goad N. Drugs That Affect Lipid Metabolism. Side Effects of Drugs Annual. 2017;39:457-464.
  • Lee SC, Groce JB III, Kim JJ. A pilot process to identify and switch high-risk warfarin patients to direct oral anticoagulants. J Hosp Admin. 2017 Sep 18;6(5):20-26.